한글목차

세계의 혈관 스텐트 시스템 시장 전망은 정맥과 동맥 시장에 기회가 있을 것입니다. 세계의 혈관 스텐트 시스템 시장은 2025-2031년 연평균 복합 성장률(CAGR) 6.9%로 성장할 것으로 예측됩니다. 이 시장의 주요 촉진요인은 심혈관 질환 유병률 증가, 스텐트 기술 진보, 노화입니다.

• Lucintel의 예측에서는 120mm가 120mm가 예측 기간 동안 최대 부문을 유지하지만, 이는 120mm가 장기간 스텐트 유치가 필요한 대규모 또는 복잡한 혈관 상태를 치료하기 위해 설계되었기 때문입니다.
• 용도별로는 심장에서 체내로 높은 압력으로 혈액을 보내는 동맥이 계속 큰 부문이 될 것으로 보입니다.
• 지역별로는 혁신적인 의료 기술의 채용이 많은 북미가 예측 기간 중 가장 높은 성장을 이룰 것으로 예측됩니다.

150페이지 이상의 종합적인 보고서를 통해 비즈니스 의사 결정에 도움이 되는 귀중한 인사이트를 얻을 수 있습니다. 몇 가지 인사이트를 포함하는 샘플 다이어그램이 아래에 나와 있습니다.

혈관 스텐트 시스템 시장의 새로운 동향

세계의 혈관 스텐트 시스템 시장은 기술의 진보, 맞춤형 치료에 대한 수요 증가, 규제 상황의 변화에 따라 변화하고 있습니다. 이러한 새로운 동향은 환자 결과 개선, 절차 효율성, 시장 접근성 확대에 중점을 둡니다.

• 생체 흡수성 스텐트 : 생체 흡수성 스텐트는 목적을 달성하면 신체에서 자연적으로 용해되어 주요 동향으로 주목을 받고 있습니다. 이러한 스텐트는 영구적인 임플란트를 필요로 하지 않으므로 영구적인 스텐트 시스템과 관련된 합병증을 줄일 수 있습니다. 이 스텐트는 특히 임시 혈관 지원이 필요한 젊은 환자에게 심혈관 계통의 장래에 주요한 담당자 중 하나가 될 것으로 보입니다. 기술이 성숙함에 따라 더욱 안전하고 효과적인 치료 옵션에 대한 수요가 증가함에 따라 생체 흡수성 스텐트는 더 많은 시장 점유율을 얻게 될 것입니다.
• 약물 용출 스텐트(DES) : 약물 용출 스텐트(DES)는 동맥에 직접 약물을 투여하여 재협착의 위험을 크게 줄이기 위해 혈관 스텐트 시장에서 중요한 개발 제품입니다. DES는 환자의 예후를 개선하고 재수술을 최소화하는 것으로 나타났기 때문에 오늘날 널리 사용되고 있습니다. 시장이 성숙함에 따라 약물전달을 더욱 강화하고 부작용을 줄이고 스텐트의 수명을 연장하는 새로운 DES 기술이 개발되고 있습니다. 이러한 추세는 다양한 환자 집단에 DES가 널리 채택될 것으로 예측됩니다.
• 저침습 기술 및 로봇 공학 : 로봇 공학과 하이엔드 영상 처리를 통한 저침습 수술이 혈관 스텐트 시장의 양상을 바꾸고 있습니다. 로봇 지원 수술은 환자의 회복 시간 및 수술 위험을 줄이면서 보다 우수한 정확성과 정밀도를 제공합니다. 이러한 기술을 사용하면 보다 복잡한 사례가 효율적인 방식으로 합병증을 줄이고 치료할 수 있습니다. 이 수요가 계속 확대되고 있는 가운데 스텐트 시스템은 로봇 시스템과의 호환성과 새로운 시각 유도 기술을 도입한 기술 혁신이 기대되고 있습니다.
• 스텐트 디자인의 맞춤화 및 개인화 : 혈관 질환의 해명이 진행됨에 따라 개별 환자의 요구에 맞는 맞춤형 디자인의 스텐트 솔루션이 나타납니다. 동맥의 크기, 질병의 진행 정도, 환자의 건강 상태 등의 요소를 고려한 스텐트의 개별화 설계가 증가하고 있습니다. 이것은 해부학 및 임상 문제에 맞게 스텐트를 사용자 정의하여 더 나은 결과를 얻을 수 있습니다. 이러한 개인화된 의료 동향은 환자별 스텐트를 설계하기 위한 많은 연구를 추진하고 시장 규모를 확대할 것으로 예측됩니다.
• 스텐트 재료의 신개발 : 재료의 혁신도 혈관 스텐트 시장의 중요한 동향 중 하나로 합병증을 일으키기 어려운 생체적합성이 높은 스텐트의 설계를 연구하고 있으며, 현재도 조사 중입니다. 생분해성 폴리머나 첨단 합금 등의 신소재는 스텐트의 성능과 안전성을 높이기 위해서 개발되고 있습니다. 신소재는 재협착율을 저하시키고 다양한 혈관 치료에서 스텐트의 효율을 향상시킬 가능성을 갖고 있습니다. 첨단 재료의 사용은 스텐트 유치술의 장기적인 성공 및 환자 만족도를 향상시킬 것으로 기대됩니다.

생체 흡수성 스텐트, 약물 용출 스텐트, 저침습 기술, 개별화된 스텐트 설계, 사용 재료 개선 등의 새로운 동향은 세계 혈관 스텐트 시스템 시장에 혁명을 일으키고 있습니다. 신제품과 신기술은 치료 성적 개선을 통해 환자에게 혜택을 주고, 스텐트 치료에 대한 접근성을 증가시키고, 세계의 헬스케어 제공 시스템에서 효율적이고 효과적인 치료를 보장할 것으로 기대되고 있습니다.

혈관 스텐트 시스템 시장의 최근 동향

혈관 스텐트 시스템 시장의 최신 개발은 고급 및 환자 친화적인 솔루션에 대한 동향을 반영합니다. 기술 혁신, 규제 진전, 업계와의 제휴를 통해 보다 안전하고 효과적이며 비용 효율적인 스텐트 개발에 중점을 두고 있습니다.

• 생체 흡수성 스텐트의 진보 : 혈관 스텐트 시장에서 가장 중요한 진보 중 하나는 생체 흡수성 스텐트이며, 이는 시간이 지남에 따라 체내에 흡수됩니다. 이 스텐트는 혈관을 일시적으로 지원하고 장기적인 합병증을 최소화하고 재수술의 필요성을 줄입니다. 기술이 성숙하고 임상 결과가 지속적으로 유망함에 따라 생체 흡수성 스텐트는 시장에서 더 큰 점유율을 차지할 것으로 예측됩니다.
• 차세대 약물 용출 스텐트 : 주요 분야 중 하나는 차세대 약물 용출 스텐트(DES)의 개발입니다. 이 스텐트는 환부의 동맥에 직접 약물을 전달하여 재 협착을 예방하고 환자의 장기 예후를 향상시킵니다. 새로운 DES 디자인은 더 효과적인 약물과 폴리머를 포함하고 스텐트의 합병증 감소 능력을 향상시켜 관상 동맥 질환 환자에게 최적의 선택입니다.
• 로봇 지원에 의한 스텐트 유치 : 로봇 지원 스텐트 유치술은 스텐트 유치술의 정확성과 안전성을 향상시켰습니다. 외과의사는 스텐트 유치를 비교적 정확하게 실시할 수 있게 되었고, 합병증의 위험도 낮고 회복 시간도 단축되었습니다. 이 기술이 보다 이용하기 쉬워지고 가격도 저렴해짐에 따라, 이 의료 행위는 많은 고급 시설이나 저자원의 환경에서도 행해질 것으로 보입니다.
• 규제 당국의 승인 강화 : FDA 및 EMA와 같은 규제 기관은 혁신적인 스텐트 시스템의 승인 프로세스를 간소화하고 보다 빠른 시장 진입을 가능하게 합니다. 이러한 규제 당국의 지원은 제조업체가 임상 결과를 개선하는 새로운 스텐트 기술의 개발을 촉구합니다. 승인을 가속화하면 혁신이 가속화되고 고급 스텐트 시스템이 환자에게보다 효율적으로 제공됩니다.
• 스텐트 제조의 세계적 확장 : 특히 신흥 시장에서 스텐트 제조 능력의 확대로 세계에서 더 저렴한 스텐트 옵션을 이용할 수 있게 되었습니다. 제조업체 각사는 아시아나 라틴아메리카 등의 지역에 생산 시설을 설립해, 현지 수요 증가나 경쟁의 격화에 대응하는 것과 동시에, 고품질의 스텐트 시스템을 보다 많은 환자가 이용할 수 있도록 하고 있습니다.

생체 흡수성 스텐트, 약물 용출성 스텐트, 로봇 지원 수술, 규제 개선, 세계 시장으로의 제조 진출 등 최근의 진보가 혈관 스텐트 시스템 시장의 성장을 뒷받침하고 있습니다. 이러한 혁신은 환자 치료의 질을 향상시키고, 치료에 대한 접근을 증가시키며, 혈관 인터벤션의 미래를 변화시킵니다.

목차

제1장 주요 요약

제2장 시장 개요

• 배경 및 분류
• 공급망

제3장 시장 동향 및 예측 분석

• 거시경제 동향 및 예측
• 업계의 촉진요인 및 과제
• PESTLE 분석
• 특허 분석
• 규제 환경

제4장 혈관 스텐트 시스템 시장 : 유형별

• 개요
• 유형별 매력 분석
• 60 mm : 동향 및 예측(2019-2031년)
• 80 mm : 동향 및 예측(2019-2031년)
• 100 mm : 동향 및 예측(2019-2031년)
• 120 mm : 동향 및 예측(2019-2031년)
• 기타 : 동향 및 예측(2019-2031년)

제5장 혈관 스텐트 시스템 시장 : 용도별

• 개요
• 용도별 매력 분석
• 정맥 : 동향 및 예측(2019-2031년)
• 동맥 : 동향 및 예측(2019-2031년)

제6장 지역 분석

• 개요
• 혈관 스텐트 시스템 시장 : 지역별

제7장 북미의 혈관 스텐트 시스템 시장

• 개요
• 북미의 혈관 스텐트 시스템 시장 : 유형별
• 북미의 혈관 스텐트 시스템 시장 : 용도별
• 미국의 혈관 스텐트 시스템 시장
• 멕시코 혈관 스텐트 시스템 시장
• 캐나다 혈관 스텐트 시스템 시장

제8장 유럽의 혈관 스텐트 시스템 시장

• 개요
• 유럽의 혈관 스텐트 시스템 시장 : 유형별
• 유럽의 혈관 스텐트 시스템 시장 : 용도별
• 독일의 혈관 스텐트 시스템 시장
• 프랑스 혈관 스텐트 시스템 시장
• 스페인의 혈관 스텐트 시스템 시장
• 이탈리아의 혈관 스텐트 시스템 시장
• 영국의 혈관 스텐트 시스템 시장

제9장 아시아태평양의 혈관 스텐트 시스템 시장

• 개요
• 아시아태평양의 혈관 스텐트 시스템 시장 : 유형별
• 아시아태평양의 혈관 스텐트 시스템 시장 : 용도별
• 일본의 혈관 스텐트 시스템 시장
• 인도의 혈관 스텐트 시스템 시장
• 중국의 혈관 스텐트 시스템 시장
• 한국의 혈관 스텐트 시스템 시장
• 인도네시아의 혈관 스텐트 시스템 시장

제10장 세계 기타 지역(ROW)의 혈관 스텐트 시스템 시장

• 개요
• ROW의 혈관 스텐트 시스템 시장 : 유형별
• ROW의 혈관 스텐트 시스템 시장 : 용도별
• 중동의 혈관 스텐트 시스템 시장
• 남미의 혈관 스텐트 시스템 시장
• 아프리카 혈관 스텐트 시스템 시장

제11장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석
  • 경쟁 기업간 경쟁 관계
  • 구매자의 협상력
  • 공급기업의 협상력
  • 대체품의 위협
  • 신규 참가업체의 위협
• 시장 점유율 분석

제12장 기회 및 전략 분석

• 밸류체인 분석
• 성장 기회 분석
  • 유형별 성장 기회
  • 용도별 성장 기회
• 세계 혈관 스텐트 시스템 시장에서의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 인증 및 라이선싱
  • 합병, 인수, 계약, 제휴 및 합작 사업

제13장 밸류체인에서 주요 기업의 기업 프로파일

• 경쟁 분석
• Boston Scientific
• Koninklijke Philips NZ
• Cook Medical
• Bentley Innomed
• Vesper Medical
• Cordis
• Abbott

제14장 부록

영문목차

The future of the global vascular stent system market looks promising with opportunities in the veins and arteries markets. The global vascular stent system market is expected to grow with a CAGR of 6.9% from 2025 to 2031. The major drivers for this market are the rising prevalence of cardiovascular diseases, advancements in stent technology, and an aging population.

• Lucintel forecasts that, within the type category, 120mm will remain the largest segment over the forecast period because it is designed to treat larger or more complex vascular conditions requiring more extended stent placements.
• Within the application category, arteries will remain the larger segment due to transporting blood under higher pressure from the heart to the body.
• In terms of region, North America is expected to witness the highest growth over the forecast period due to the high adoption of innovative medical technologies.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Vascular Stent System Market

The global vascular stent system market is changing with technological advancements, increased demand for personalized treatments, and regulatory changes that are reshaping the landscape. These emerging trends are focused on improving patient outcomes, enhancing the efficiency of procedures, and expanding market access.

• Bioresorbable Stents: Bioresorbable stents naturally dissolve in the body after serving their purpose and are gaining traction as a leading trend. These stents obviate the need for permanent implants, which reduces complications associated with permanent stent systems. They will be one of the major players in the future of cardiovascular interventions, especially for younger patients requiring temporary vascular support. As the technology matures, bioresorbable stents will capture more market share due to the increasing demand for safer and more effective treatment options.
• Drug-Eluting Stents (DES): Drug-eluting stents (DES) are the critical development in the vascular stent market as they significantly reduce the risk of restenosis, which occurs through direct medication delivery to the artery. DES use is widespread today as they have been shown to improve the outcome for the patient and minimize follow-up procedures. As the market matures, newer DES technologies are being developed to enhance drug delivery further, reduce side effects, and extend the lifespan of the stent. This trend is expected to lead to broader adoption of DES across diverse patient populations.
• Minimally Invasive Techniques and Robotics: Minimally invasive procedures with the support of robotics and high-end imaging are changing the face of the vascular stent market. Robotic-assisted surgery offers better accuracy and precision while reducing recovery times for patients and surgical risks. These technologies make more complex cases treatable in an efficient manner and with fewer complications. As this demand continues to grow, stent systems are expected to see innovation that incorporates compatibility with robotic systems and further visual guidance technologies.
• Customized and Personalized Stent Designs: The growth in understanding vascular diseases results in the rise of custom-designed stent solutions tailored to suit the individual patients' needs. Personalized designs of stents, taking into account factors like artery size, disease progression, and health condition of the patient, are on the rise. With this, more successful results may be seen due to customized stents for distinct anatomical and clinical issues. This trend in personalized medicine is also expected to propel a lot of research into the design of patient-specific stents, which will increase the market scope.
• New Developments in Stent Materials: Material innovation is another significant trend in the vascular stent market; it is still under investigation, studying the design of biocompatible stents that would be less likely to cause complications. New materials, including biodegradable polymers and advanced alloys, are being developed to make stents better in performance and safety. The new materials have the potential to reduce restenosis rates and improve the efficiency of stents in various vascular procedures. It is expected that the use of advanced materials will enhance the long-term success and patient satisfaction of stenting procedures.

New trends, such as bioresorbable stents, drug-eluting stents, minimally invasive techniques, personalized stent designs, and improvements in the material used, are revolutionizing the vascular stent system market around the world. The new products and technologies are expected to benefit patients through improved outcomes and to increase access to stent treatment, ensuring efficient and effective treatments in healthcare delivery systems across the globe.

Recent Developments in the Vascular Stent System Market

The latest developments in the vascular stent system market reflect the trend toward advanced and patient-friendly solutions. Emphasis has been placed on developing safer, more effective, and cost-efficient stents through technological innovation, regulatory advancements, and industry partnerships.

• Advancements in Bioresorbable Stents: One of the most significant advancements in the vascular stent market is bioresorbable stents, which are absorbed by the body over time. These stents provide temporary support to blood vessels, minimize long-term complications, and reduce the need for follow-up procedures. As the technology matures and clinical results continue to show promise, bioresorbable stents are expected to capture a larger share of the market.
• Next-Generation Drug-Eluting Stents: One of the key areas is the development of next-generation drug-eluting stents (DES). These stents deliver medication directly to the affected arteries, thereby preventing restenosis and ensuring better long-term outcomes for patients. Newer DES designs include more effective drugs and polymers that enhance the stent's ability to reduce complications, making them a go-to option for patients with coronary artery disease.
• Robotic-Assisted Stent Placement: Robotic-assisted stent placement has changed the art of delivering precision and safety in stent procedures. Surgeons can now perform the implantation of stents with relative accuracy, hence lower risks for complications and shorter recovery time. As the technology is made more accessible and affordable, this medical practice is likely to take its way into many high-end facilities and many low-resource settings.
• Enhanced Regulatory Approvals: Regulatory bodies like the FDA and EMA have streamlined the approval process for innovative stent systems, allowing for quicker market entry. This regulatory support has encouraged manufacturers to develop new stent technologies that improve clinical outcomes. Faster approvals have accelerated innovation and brought advanced stent systems to patients more efficiently.
• Global Expansion of Stent Manufacturing: The expansion of stent manufacturing capabilities, especially in emerging markets, has made more affordable stent options available worldwide. Manufacturers are establishing production facilities in regions like Asia and Latin America to cater to growing local demand, increasing competition, and making high-quality stent systems more accessible to a wider patient population.

Recent advancements such as bioresorbable stents, drug-eluting stents, robotic-assisted surgery, regulatory improvements, and the expansion of manufacturing into global markets are fueling the growth of the vascular stent system market. These innovations improve the quality of patient care, increase access to treatments, and transform the future of vascular interventions.

Strategic Growth Opportunities in the Vascular Stent System Market

The vascular stent system market provides several strategic growth opportunities across applications, underlined by demand from the advance in materials, technology, and patient care. The worldwide population, which is growing, and the global population continuing to age, is also enhancing demand for products like these.

• Expansion in Emerging Markets: Emerging markets in Asia, Latin America, and Africa present massive growth opportunities for stent manufacturers. Improved healthcare access, rising cardiovascular diseases prevalence, and strong demand for vascular stents ensure an increase in growth in these areas. Large populations with less service access, on whom the companies are venturing to expand, also enhance the expansion of this market.
• Customized Stent Solutions: Advances in personalized medicine open doors for stent manufacturers to design customized stent solutions based on the specific needs of the patient. Advances in imaging technologies and 3D printing enable the production of patient-specific stents, which leads to better results and satisfaction for treatment procedures.
• Consistent with Minimally Invasive Technologies: Manufacturers will have a golden opportunity to innovate with the introduction of stent systems that integrate minimally invasive technologies, including robotic-assisted surgery and advanced imaging techniques. Such technologies provide the exact reproduction of stent placement to decrease complication rates and shorten recovery times for patients' appeal, while the healthcare providers are not left behind to have their space.
• Regenerative Medicine in Stent Design: It can lead the stent market to a more open growth stage by integrating it with vascular stent technology, regenerative medicine. The use of stem cells or bioactive substances within the design may help enhance the healing of vessels further and decrease chances of complications, such as restenosis.
• The drug-eluting and bioresorbable stents: The increasing demand for drug-eluting and bioresorbable stents is an excellent opportunity for manufacturers to focus on developing next-generation stents. These stents offer significant advantages over traditional ones, including improved efficacy, fewer complications, and better long-term patient outcomes.

Expansion opportunities in the vascular stent system market include emerging markets, personalized stent solutions, integration with minimally invasive technologies, regenerative medicine applications, and a focus on drug-eluting and bioresorbable stents. All these will be the factors driving the market forward and furthering patient care around the world.

Vascular Stent System Market Driver and Challenges

The majority of the factors in the vascular stent system market are technology-intensive, economic, and regulatory. Knowing these drivers and challenges is important for market players for the full exploitation of opportunities and the optimization of market pay-offs.

The factors responsible for driving the vascular stent system market include:

1. Technological Advancements: Major factors driving the market are continuous technological advancements in stent materials, design, and delivery mechanisms. Improved patient outcomes due to innovations like bioresorbable stents, drug-eluting stents, and robotic-assisted stent placement increase demand for more advanced solutions.

2. Increasing Prevalence of Cardiovascular Diseases: Rising cases of cardiovascular diseases, more importantly, in the aging population, are providing ample growth for vascular stents. As the incidence of heart disease continues to rise globally, the requirement for effective and reliable stent systems grows, opening a huge growth opportunity in the market.

3. Accessibility and Affordability Healthcare: Improved healthcare infrastructure, especially in emerging markets, is boosting demand for vascular stents. As healthcare becomes more accessible and affordable, more patients are able to undergo stenting procedures, driving market expansion.

4. Regulatory Approvals and Reimbursement Policies: Favorable regulatory policies and improved reimbursement systems are the most important drivers for market growth. Faster approval processes for new stent technologies and favorable reimbursement policies encourage manufacturers to introduce innovative products into the market, facilitating market expansion.

5. Increasing Focus on Minimally Invasive Procedures: The growing preference for minimally invasive procedures is another significant driver of market growth. With advantages such as shorter recovery times and fewer complications, minimally invasive stent placements are gaining popularity, contributing to the overall demand for advanced stent systems.

Challenges in the vascular stent system market are:

1. High Production Costs: The high cost of manufacturing advanced stents, particularly drug-eluting and bioresorbable stents, poses a challenge for market growth. These high production costs can limit the affordability and availability of cutting-edge stent technologies, especially in lower-income regions.

2. Regulatory Hurdles: Despite positive trends, there are challenges associated with the intricate regulatory environment across regions. The regulatory bodies demand high safety, efficacy, and quality standards, which delay the product development process and entry into the market for stent manufacturers.

3. Risk of Restenosis and Complications: Although there have been great improvements in stent technology, restenosis (re-narrowing of arteries) and other complications, such as thrombosis, remain risks associated with stent use. These challenges require ongoing innovation to develop safer, more effective stent systems.

Technological advancement in the vascular stent system is foremost, followed by an increased occurrence of cardiovascular diseases, improved health access, and favorable regulations. The major challenges that face the market are mainly production cost, regulatory hurdles, and the risk of restenosis.

List of Vascular Stent System Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, vascular stent system companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the vascular stent system companies profiled in this report include-

• Boston Scientific
• Koninklijke Philips NV
• Cook Medical
• Bentley Innomed
• Vesper Medical
• Cordis
• Abbott

Vascular Stent System Market by Segment

The study includes a forecast for the global vascular stent system market by type, application, and region.

Vascular Stent System Market by Type [Value from 2019 to 2031]:

• 60Mm
• 80Mm
• 100Mm
• 120Mm
• Others

Vascular Stent System Market by Application [Value from 2019 to 2031]:

• Veins
• Arteries

Vascular Stent System Market by Region [Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Vascular Stent System Market

The global vascular stent system market has grown significantly in the last few years due to technological advancements, increasing prevalence of vascular diseases, and rising awareness about minimally invasive procedures. As medical professionals and companies focus on improving patient outcomes, innovation in stent materials, design, and delivery methods has been pivotal. The United States, China, Germany, India, and Japan are the key markets that are progressing with significant investment in research and development, along with improvements in regulations and increased healthcare infrastructure.

• United States: The vascular stent system market in the United States is growing rapidly due to advanced bioresorbable stents, which can be used temporarily to remove obstructions in blood vessels. There are various new-generation drug-eluting stents (DES) approved by the FDA, which release medication for preventing restenosis, or re-narrowing of arteries. The incidence of cardiovascular diseases is also rising, and healthcare infrastructure is improving along with reimbursement policies. In addition, the use of robotic-assisted surgeries and advanced imaging technologies has made stent placement more precise and minimally invasive.
• China: The vascular stent system market in China is growing rapidly because of the increasing incidence of cardiovascular diseases in the country and improvements in healthcare delivery. Local manufacturers are increasingly producing affordable, high-quality stents to cater to both domestic and international markets. Chinese regulators have streamlined approval processes for medical devices, encouraging innovation and entry into the market. There is a growing need for advanced stent technologies, including bioresorbable and drug-eluting stents, due to the fact that Chinese physicians are now emphasizing patient outcomes by developing individualized treatment plans. Moreover, rapid modernization in China's healthcare system will further expand these technologies.
• Germany: Germany is one of the leaders in medical technology. The country has experienced great improvements in the vascular stent system market. Drug-eluting and bioresorbable stents are among the leading products, with the leading players investing much in R&D to enhance stent performance and minimize complications. The German market benefits from the strict regulatory standards that ensure high-quality stent systems for patients. Widespread provisions under Germany's healthcare system for vascular interventions help make stent technologies more accessible. Integration of advanced imaging and robotic systems into surgery has helped the precision and efficiency of stent placement.
• India: The Indian vascular stent system market is burgeoning with rapid growth attributed to the increasing burden of cardiovascular diseases and widespread awareness of the benefits of stenting procedures. Through government initiatives and foreign investment, India has developed a competitive market for affordable stents catering to both domestic and international needs. Indian manufacturers are adopting global standards, producing high-quality stents, including drug-eluting and bioresorbable, at lower costs. In addition, improvements in the healthcare infrastructure and access to advanced technologies also increase vascular interventions within a larger population in this country.
• Japan: Vascular stent technology is one of the leaders in Japan, with thorough and consistent research and development to make these stent systems even safer and more effective. In this market, there has been massive demand for high-quality drug-eluting stents that prevent the re-narrowing of arteries after stent placement. Bioresorbable stents are another development being invested in Japan and are expected to be a big market driver. Advanced imaging techniques by Japanese healthcare providers are also utilized for finer accuracy of stent placement. The country's elderly population has been contributing to the increasing demand for efficient vascular interventions and stenting solutions.

Features of the Global Vascular Stent System Market

• Market Size Estimates: Vascular stent system market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
• Segmentation Analysis: Vascular stent system market size by type, application, and region in terms of value ($B).
• Regional Analysis: Vascular stent system market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the vascular stent system market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the vascular stent system market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the vascular stent system market by type (60mm, 80mm, 100mm, 120mm, and others), application (veins and arteries), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

• 2.1 Background and Classifications
• 2.2 Supply Chain

3. Market Trends & Forecast Analysis

• 3.1 Macroeconomic Trends and Forecasts
• 3.2 Industry Drivers and Challenges
• 3.3 PESTLE Analysis
• 3.4 Patent Analysis
• 3.5 Regulatory Environment

4. Global Vascular Stent System Market by Type

• 4.1 Overview
• 4.2 Attractiveness Analysis by Type
• 4.3 60 mm: Trends and Forecast (2019-2031)
• 4.4 80 mm: Trends and Forecast (2019-2031)
• 4.5 100 mm: Trends and Forecast (2019-2031)
• 4.6 120 mm: Trends and Forecast (2019-2031)
• 4.7 Others: Trends and Forecast (2019-2031)

5. Global Vascular Stent System Market by Application

• 5.1 Overview
• 5.2 Attractiveness Analysis by Application
• 5.3 Veins: Trends and Forecast (2019-2031)
• 5.4 Arteries: Trends and Forecast (2019-2031)

6. Regional Analysis

• 6.1 Overview
• 6.2 Global Vascular Stent System Market by Region

7. North American Vascular Stent System Market

• 7.1 Overview
• 7.2 North American Vascular Stent System Market by Type
• 7.3 North American Vascular Stent System Market by Application
• 7.4 United States Vascular Stent System Market
• 7.5 Mexican Vascular Stent System Market
• 7.6 Canadian Vascular Stent System Market

8. European Vascular Stent System Market

• 8.1 Overview
• 8.2 European Vascular Stent System Market by Type
• 8.3 European Vascular Stent System Market by Application
• 8.4 German Vascular Stent System Market
• 8.5 French Vascular Stent System Market
• 8.6 Spanish Vascular Stent System Market
• 8.7 Italian Vascular Stent System Market
• 8.8 United Kingdom Vascular Stent System Market

9. APAC Vascular Stent System Market

• 9.1 Overview
• 9.2 APAC Vascular Stent System Market by Type
• 9.3 APAC Vascular Stent System Market by Application
• 9.4 Japanese Vascular Stent System Market
• 9.5 Indian Vascular Stent System Market
• 9.6 Chinese Vascular Stent System Market
• 9.7 South Korean Vascular Stent System Market
• 9.8 Indonesian Vascular Stent System Market

10. ROW Vascular Stent System Market

• 10.1 Overview
• 10.2 ROW Vascular Stent System Market by Type
• 10.3 ROW Vascular Stent System Market by Application
• 10.4 Middle Eastern Vascular Stent System Market
• 10.5 South American Vascular Stent System Market
• 10.6 African Vascular Stent System Market

11. Competitor Analysis

• 11.1 Product Portfolio Analysis
• 11.2 Operational Integration
• 11.3 Porter's Five Forces Analysis
  • Competitive Rivalry
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Threat of Substitutes
  • Threat of New Entrants
• 11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

• 12.1 Value Chain Analysis
• 12.2 Growth Opportunity Analysis
  • 12.2.1 Growth Opportunities by Type
  • 12.2.2 Growth Opportunities by Application
• 12.3 Emerging Trends in the Global Vascular Stent System Market
• 12.4 Strategic Analysis
  • 12.4.1 New Product Development
  • 12.4.2 Certification and Licensing
  • 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

• 13.1 Competitive Analysis
• 13.2 Boston Scientific
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.3 Koninklijke Philips NV
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.4 Cook Medical
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.5 Bentley Innomed
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.6 Vesper Medical
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.7 Cordis
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing
• 13.8 Abbott
  • Company Overview
  • Vascular Stent System Business Overview
  • New Product Development
  • Merger, Acquisition, and Collaboration
  • Certification and Licensing

14. Appendix

• 14.1 List of Figures
• 14.2 List of Tables
• 14.3 Research Methodology
• 14.4 Disclaimer
• 14.5 Copyright
• 14.6 Abbreviations and Technical Units
• 14.7 About Us
• 14.8 Contact Us